Additionally, the study sheds light on the tumorigenic capabilities of UCN and GABRD, linking these genes to pivotal pathways known to drive cancer progression, such as MYC targets V1, MYC targets V2, and DNA repair pathways. This evidence concerns the gene MYC and cancer.